Absolute Indications for Influenza Vaccination
Annual influenza vaccination is universally recommended for all persons aged ≥6 months without contraindications, making it essentially an absolute indication for the entire population rather than select groups. 1, 2
Universal Vaccination Recommendation
The most recent ACIP guidelines establish that routine annual influenza vaccination should be administered to everyone aged ≥6 months who does not have a contraindication 1, 2. This represents a shift from earlier risk-based approaches to a universal vaccination strategy, eliminating the concept of "absolute" versus "relative" indications in the traditional sense.
Priority Groups When Vaccine Supply is Limited
While vaccination is recommended universally, certain populations warrant prioritized vaccination efforts due to higher risk of severe complications and mortality:
High-Risk Medical Conditions (All Ages)
- Chronic pulmonary diseases including asthma and cystic fibrosis
- Cardiovascular disease (excluding isolated hypertension)
- Chronic metabolic diseases including diabetes mellitus
- Renal and hepatic disorders
- Neurologic and neurodevelopmental disorders
- Immunocompromising conditions from any cause (medications, HIV, malignancy)
- Hemoglobinopathies including sickle cell disease
- Children/adolescents on long-term aspirin therapy (risk of Reye syndrome) 1, 3
Age-Based Priority Groups
- All children aged 6-59 months (under 5 years)
- All persons aged ≥50 years 1
- Residents of nursing homes and long-term care facilities 1
Pregnancy and Postpartum
- All women who are or will be pregnant during influenza season (any trimester)
- Postpartum women who did not receive vaccination during pregnancy
- Breastfeeding women 3, 1
Occupational and Contact Groups
- All healthcare personnel (paid and unpaid, including students and volunteers)
- Household contacts and caregivers of:
Special Populations
- American Indian or Alaska Native persons
- Persons with extreme obesity (BMI ≥40 for adults) 1
Key Clinical Considerations
Timing: Vaccination should ideally occur by the end of October, though it should continue to be offered throughout the influenza season as long as virus is circulating 4, 1.
Children aged 6 months through 8 years: May require 2 doses (administered ≥4 weeks apart) if they have not been previously vaccinated or have received fewer than 2 lifetime doses 3.
Vaccine selection: Inactivated influenza vaccine (IIV) or recombinant influenza vaccine (RIV) are preferred for all populations. Live attenuated influenza vaccine (LAIV) has specific contraindications and is not recommended as first-line 3.
Absolute Contraindications
The only true absolute contraindication is:
- History of severe allergic reaction to any vaccine component or previous dose of influenza vaccine 5
Important caveat: Egg allergy is NOT a contraindication. Persons with egg allergy of any severity can receive influenza vaccine without additional precautions beyond standard vaccine administration protocols 3, 5.